Coherus BioSciences has completed the sale of its Udenyca (pegfilgrastim-cbqv) franchise to Intas Pharmaceuticals ... in combination with Loqtorzi to key data milestones in 2026, and progressing ...

Last November, an employee at Intas Pharmaceuticals, which makes several widely used chemotherapies that are in short supply, was seen pouring acetic acid in a trash bin containing documents at a ...

said the second person, also on condition of anonymity. ALSO READ | ChrysCapital set to exit Eris Lifesciences in $200 million IPO When contacted, an Intas spokesperson confirmed the development ...

Aurobindo Pharma and Intas are in the race to buy UK-based Mallinckrodt's generic drugs business in the US, sources said. The deal valued at USD 2 billion, will be the biggest ever overseas ...